P2X and P2Y nucleotide receptors as targets in cardiovascular disease
- PMID: 23495690
- DOI: 10.4155/fmc.13.6
P2X and P2Y nucleotide receptors as targets in cardiovascular disease
Abstract
Endogenous nucleotides have widespread actions in the cardiovascular system, but it is only recently that the P2X and P2Y receptor subtypes, at which they act, have been identified and subtype-selective agonists and antagonists developed. These advances have greatly increased our understanding of the physiological and pathophysiological functions of P2X and P2Y receptors, but investigation of the clinical usefulness of selective ligands is at an early stage. Nonetheless, the evidence considered in this review demonstrates clearly that various cardiovascular disorders, including vasospasm, hypertension, congestive heart failure and cardiac damage during ischemic episodes, may be viable targets. With further development of novel, selective agonists and antagonists, our understanding will continue to improve and further therapeutic applications are likely to be discovered.
Similar articles
-
Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.Immunobiology. 2011 Jan-Feb;216(1-2):1-11. doi: 10.1016/j.imbio.2010.03.010. Epub 2010 Apr 9. Immunobiology. 2011. PMID: 20471713
-
The P2Y/P2X divide: How it began.Biochem Pharmacol. 2021 May;187:114408. doi: 10.1016/j.bcp.2021.114408. Epub 2021 Jan 11. Biochem Pharmacol. 2021. PMID: 33444568 Review.
-
Recommended tool compounds and drugs for blocking P2X and P2Y receptors.Purinergic Signal. 2021 Dec;17(4):633-648. doi: 10.1007/s11302-021-09813-7. Epub 2021 Sep 2. Purinergic Signal. 2021. PMID: 34476721 Free PMC article. Review.
-
Functional expression of P2 receptors in the inner ear of chicken embryo.Neurosci Lett. 2013 Oct 11;553:24-8. doi: 10.1016/j.neulet.2013.08.010. Epub 2013 Aug 14. Neurosci Lett. 2013. PMID: 23954824
-
Purinergic P2X receptors: structural models and analysis of ligand-target interaction.Eur J Med Chem. 2015 Jan 7;89:561-80. doi: 10.1016/j.ejmech.2014.10.071. Epub 2014 Oct 25. Eur J Med Chem. 2015. PMID: 25462266
Cited by
-
Characterisation of P2Y receptor subtypes mediating vasodilation and vasoconstriction of rat pulmonary artery using selective antagonists.Purinergic Signal. 2022 Dec;18(4):515-528. doi: 10.1007/s11302-022-09895-x. Epub 2022 Aug 26. Purinergic Signal. 2022. PMID: 36018534 Free PMC article.
-
Array data extractor (ADE): a LabVIEW program to extract and merge gene array data.BMC Res Notes. 2013 Dec 1;6:496. doi: 10.1186/1756-0500-6-496. BMC Res Notes. 2013. PMID: 24289243 Free PMC article.
-
Control of bone development by P2X and P2Y receptors expressed in mesenchymal and hematopoietic cells.Gene. 2015 Oct 1;570(1):1-7. doi: 10.1016/j.gene.2015.06.031. Epub 2015 Jun 14. Gene. 2015. PMID: 26079571 Free PMC article. Review.
-
Characterization of purinergic receptor expression in ARPKD cystic epithelia.Purinergic Signal. 2018 Dec;14(4):485-497. doi: 10.1007/s11302-018-9632-5. Epub 2018 Nov 11. Purinergic Signal. 2018. PMID: 30417216 Free PMC article.
-
Dynamic changes in purine catabolism in patients with acute coronary syndrome that underwent percutaneous coronary intervention.Caspian J Intern Med. 2019 Winter;10(1):86-91. doi: 10.22088/cjim.10.1.86. Caspian J Intern Med. 2019. PMID: 30858946 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases